Basic Information
Experimental Physicochemical Property
| Property Name | Property Value | Unit | Raw Value | Raw Unit | Reference |
|---|---|---|---|---|---|
| Boiling Point | 200.0 | ℃ | >200 | ℃ | MSDS |
| Melting Point | 59.5 | ℃ | 58-61 | ℃ | MSDS |
Pharmacokinetic/ Toxicokinetic Property
| Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
|---|---|---|---|---|---|---|
| C Max | 2700.0 | ng/ml | 2.7 | mcg/ml | Liquid; | DRUGBANK |
| T Max | 3.0 | h | 3 | h | Liquid; | DRUGBANK |
| Volume of Distribution | 48481.0 | L | 48481.0 | L | Average volume of distribution; Liquid; normal,healthy; | DRUGBANK |
| Half-life | 4.1 | h | 4.1 | h | normal,healthy; Liquid; | DRUGBANK |
| Toxicity LD50 | 22000.0 | mg/kg | 22000.0 | mg/kg | PO, oral; Rattus, Rat; | DRUGBANK |
| Eliminate Route | 92.0 | % | 85-99 | % | Faeces excretion; PO, oral; normal,healthy; human, homo sapiens; | DRUGBANK |
Maximum Dosage
| Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Brand Name | Component | Reference |
|---|---|---|---|---|---|---|---|---|
| Max dose for infants | 1100.0 | mg/kg/day | 1.1 | g/kg/day | PO, oral | MiraLax | polyethylene glycol 3350 | PDR |
| Max dose for children | 800.0 | mg/kg/day | 0.8 | g/kg/day | PO, oral | MiraLax | polyethylene glycol 3350 | PDR |
| Max dose for children | 17000.0 | mg/day | 17 | g/day | PO, oral | MiraLax | polyethylene glycol 3350 | PDR |
| Max dose for children | 1500.0 | mg/kg/day | 1.5 | g/kg/day | PO, oral; up to 3 days | MiraLax | polyethylene glycol 3350 | PDR |
| Max dose for children | 100000.0 | mg/day | 100 | g/day | PO, oral; up to 3 days | MiraLax | polyethylene glycol 3350 | PDR |
| Max dose for children | 1100.0 | mg/kg/day | 1.1 | g/kg/day | PO, oral | MiraLax | polyethylene glycol 3350 | PDR |
| Max dose for adolescents | 17000.0 | mg/day | 17 | g/day | PO, oral | MiraLax | polyethylene glycol 3350 | PDR |
| Max dose for adolescents | 34000.0 | mg/day | 34 | g/day | PO, oral | MiraLax | polyethylene glycol 3350 | PDR |
| Max dose for adolescents | 800.0 | mg/kg/day | 0.8 | g/kg/day | PO, oral | MiraLax | polyethylene glycol 3350 | PDR |
| Max dose for adolescents | 17000.0 | mg/day | 17 | g/day | PO, oral | MiraLax | polyethylene glycol 3350 | PDR |
| Max dose for adolescents | 1500.0 | mg/kg/day | 1.5 | g/kg/day | PO, oral; up to 3 days | MiraLax | polyethylene glycol 3350 | PDR |
| Max dose for adolescents | 100000.0 | mg/day | 100 | g/day | PO, oral; up to 3 days | MiraLax | polyethylene glycol 3350 | PDR |
| Max dose for adults | 34000.0 | mg/day | 34 | g/day | PO, oral | MiraLax | polyethylene glycol 3350 | PDR |
| Max dose for geriatric | 34000.0 | mg/day | 34 | g/day | PO, oral | MiraLax | polyethylene glycol 3350 | PDR |
Drug Property Radar Chart
Note: Center: Q1-1.5*IQR, Edge: Q3+1.5*IQR; Q1: Quantile 1, Q3: Quantile 3, IQR: Q3-Q1